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Abstract
Background: Obesity in type 2 diabetes patients is a serious health issue by itself; it is also associated with other health prob-
lems including psychiatric illnesses. The psychological effects of  dieting and weight loss have been a matter of  controversy 
in the field of  obesity management.
Objective: The aim of  this study was to compare the impact of  weight loss because of  aerobic exercise training and dietary 
measures on psychological wellbeing and biochemical modulation in obese type 2 diabetes patients. 
Material and methods: One hundred obese type 2 diabetes patients of  both sexes participated in this study, and were in-
cluded into two equal groups. The first group (A) received aerobic exercise training, three sessions per week for three months 
combined with dietary measures. The second group (B) received no training intervention for three months. 
Results: There was a significant decrease in body mass index (BMI), leptin, total cholesterol (TC), low density lipoprotein 
cholesterol (LDL-c), triglycerides(TG), homeostasis model assessment-insulin resistance- index (HOMA-IR) , beck depres-
sion inventory (BDI )  & profile of  mood states(POMS) and  increase in high density lipoprotein cholesterol (HDL-c) & 
Rosenberg self-esteem scale (RSES) of  group (A) after treatments, but the changes of  group (B) were not significant. More-
over, there were significant differences between mean levels of  the investigated parameters of  group (B) and group (A) at 
the end of  the study.
Conclusion: Physical training and dietary measures can be used as methods of  choice for psychological wellbeing and bio-
chemical modulation in obese type 2 diabetes patients. 
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Introduction
The global prevalence of  type 2 diabetes has been rising 
steadily over the past 3 decades, and is largely attrib-
utable to the dramatic increase in obesity rate1,2. Over 
300 million people worldwide live with diabetes now, 
and if  the current prevalence rate continues unabated, 
over 550 million people will be living with diabetes by 
20303,4. Diabetes represents a major health problem be-
cause of  its high prevalence, morbidity and mortality, 
its influence on patient quality of  life, and its impact on 
the health system5. It is now widely accepted that the 
obesity epidemic continues to be the principal driver for 
the rising global prevalence of  type 2 diabetes mellitus6, 
cardiovascular disease, musculoskeletal disease, cancers 
and all-cause mortality7.  
 
Type 2 diabetes mellitus is a serious chronic disease 
whereby the body is unable to effectively use glucose as 
a fuel due to relative insulin deficiency caused by insulin 
resistance8.  Untreated acute and chronic states of  hy-
perglycemia could lead to debilitating long-term com-
plications. Heart attacks and strokes are two to three 
fold higher in people with diabetes, along with increased 
risks for retinopathy, nephropathy and neuropathy. Life 
expectancy can be shortened by as much as 10-15 years 
because of  premature and accelerated atherosclerosis, 
and the attendant medical complications9. 
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Depression is a health complication that is commonly 
associated with obesity as risk of  depression is 20–50% 
higher among obese individuals than normal weight 
persons10,11. Extremely obese persons are at even greater 
risk12. The relationship between obesity and depression 
appears to be bi-directional; some longitudinal studies 
have shown that depression is associated with subse-
quent weight gain and obesity13-15, whereas others have 
found that obesity is associated with the development 
of  depression16,17.  
 
As the lifetime risk of  diabetes increases substantially 
and proportionally with the magnitude of  overweight 
and obesity18, a major effort of  the fight against diabe-
tes is focused on diabetes prevention through weight 
loss and health behavior changes, and aggressive gly-
cemic and overall management of  diabetes to prevent 
the deadly complications18,19.  However, health behav-
ior modification, aiming at achieving a healthier body 
weight through dietary therapy and regular physical 
activity, is the cornerstone therapy for people with di-
abetes recommended by the American Diabetes As-
sociation20. The 2013 American Diabetes Association 
standards of  medical care in diabetes guidelines recom-
mend a 7% body weight loss for all overweight or obese 
individuals who have or are at risk for diabetes through 
dietary strategies and regular physical activity21. Physical 
activity combined with calorie restriction improves not 
only parameters of  well-being and prevention of  major 
morbidity but also embeds longer-term weight mainte-
nance22,23. 
The aim of  this study was to measure the impact of  
weight loss because of  aerobic exercise training and die-
tary measures on psychological wellbeing and biochem-
ical modulation in obese type 2 diabetes patients 
Patients and methods
Subjects
One hundred obese type 2 diabetes patients of  both 
sexes (56 males & 44 females) were randomly selected 
from the Internal Medicine Department at King Abdul 
Aziz University hospital and other hospitals at Jeddah 
area. Their age was between 35 - 45 years, the body mass 
index (BMI) ranged from 32 to 36 Kg/m2, free from 
other co-morbidities as respiratory, kidney, liver, neu-
rological disorders and orthopedic problems inhibiting 
treadmill training or renal disease. Participants were in-
cluded into two equal groups; the first group (A) re-
ceived aerobic exercise training, three sessions per week 
for three months combined with dietary measures. The 
second group (B) received no training intervention for 
three months. Informed consent was obtained from all 
participants. All participants were in sedentary lifestyle 
prior to the study and they received only oral hypogly-
cemic drugs and did not receive any medications, which 
can affect the mood, moreover they were free to with-
draw from the study at any time. 
 
Equipment
1) Treadmill (Enraf  Nonium, Model display panel 
Standard, NR 1475.801, Holland) was used in perfor-
mance of  aerobic walking exercise.
2) Commercial kits (Randox, Tokyo, Japan) with 
K2EDTA was used to measure leptin, total cholester-
ol, triacylglycerol, high-density lipoprotein cholesterol, 
low-density lipoprotein cholesterol. 
3) Rosenberg self-esteem scale (RSES) was used for 
self-esteem evaluation, the profile of  mood states 
(POMS) was used for mood disturbance evaluation and 
Beck depression inventory (BDI) was used for Depres-
sion evaluation24.  
4) Weight and height scale (JENIX DS 102, Dongsang, 
South Korea) was used to measure weight and height to 
calculate the body mass index (BMI). Body mass index 
was calculated by dividing the weight in kilograms by 
the square of  the height in meters (Kg/m2). According 
to the WHO classification, a BMI of  <18.5 Kg/m2 is 
under weight, 18.5-24.9 Kg/m2 is normal 25-29.9 Kg/
m2 is overweight. A BMI of  > 30 Kg/m2 is classified as 
obese and this group was further divided into moderate 
obesity (30-34.9 Kg/m2), sever obesity (35-39.9 Kg/m2) 
and very severe obesity (≥40 Kg/m2).
Measurements
1. Laboratory analysis:
Venous blood samples were collected in polystyrene 
tubes after a 12-h fasting, by venipuncture of  the an-
tecubital vein while patients rested in a supine position. 
The blood samples were transported to a laboratory 
within 1 h and centrifuged at + 4 °C to remove serum 
(1000 = g for 10 min). Plasma sample with K2EDTA 
was collected after centrifugation (2000 × g for 10 min 
at 4°C) and stored at −80°C to analyze leptin, total cho-
lesterol, triacylglycerol, high-density lipoprotein choles-
terol, low-density lipoprotein cholesterol. All analyses 
were carried out on a Hitachi 7170 Autoanalyser (To-
kyo, Japan) or with commercial kits (Randox). Also, kits 
(Bioclin, Quibasa, Belo Horizonte, MG, Brazil) were 
used to measure homeostasis model assessment-insulin 
resistance (HOMA-IR) index for insulin sensitivity.
2. Psychological well-being
Data was collected at baseline and at the end of  treat-
ment. Participants were asked to attend two laboratory 
sessions in order to complete all psychological assess-
ments, in each evaluation period. Self-esteem was as-
sessed with the Rosenberg self-esteem scale (RSES), a 
10-item scale that measures global self-worth by meas-
uring both positive and negative feelings about the self. 
The scale is believed to be unidimensional. All items are
answered using a 4-point Likert scale format ranging 
from strongly agree to strongly disagree.  Mood dis-
turbance was assessed with the profile of  mood states 
(POMS). Originally, the POMS included sixty five items 
which load on seven different scales: “depression”, 
“anxiety”, “fatigue”, “vigour”, “irritability”, “tension”, 
and “confusion”. The questions refer to the time period 
of  the “last week including today”. The response scale 
is divided into five categories ranging from “not at all” 
to “very strong”. The items are defined from 1 to 5 
(“not at all”, “a little”, “moderately”, “quite a bit”, and 
"extremely”, respectively). The questionnaire assessed 
six dimensions of  mood that can be used to calculate 
a total mood disturbance score, which was used in the 
present study. Questions pertain to emotional states of  
the previous month. Depression was evaluated with the 
Beck depression inventory (BDI), a 21-item inventory 
measuring several symptoms of  depression. It uses a 
4-point ordered scale and results in a total score (Items 
1 - 3 assess symptoms that are psychological in nature, 
while items 14 - 21 assess more physical symptoms. This 
was rated as follows: 1 - 10: Normal; 11 - 16: Mild mood 
disturbance; 17 - 20: Borderline clinical depression; 21 - 
30: Moderate depression and >30: Severe depression)24. 
3. Evaluation of  anthropometric parameters 
All measurements were performed at pretreatment and 
after three months at the end of  the study. The par-
ticipants were measured whilst wearing their undergar-
ments and hospital gowns. Height was measured with 
a digital stadiometer to the nearest 0.1 cm (JENIX DS 
102, Dongsang, South Korea). Body weight was meas-
ured on a calibrated balance scale to the nearest 0.1 kg 
(HC4211, Cas Korea, South Korea), and body mass 
index (BMI) was calculated as BMI = Body weight / 
(Height)2. 
All measurements of  leptin, total cholesterol, triacylg-
lycerol, high-density lipoprotein cholesterol, low-densi-
ty lipoprotein cholesterol, BMI, HOMA-IR, BDI and 
POMS were taken before the starting of  the study (pre-




Following the previous evaluation, all patients were di-
vided randomly into the following groups:
1. Patients in Group (A) were submitted to  forty 
minutes moderate intensity aerobic exercise sessions 
on a treadmill (the initial, 5-minute warm-up phase per-
formed on the treadmill (Enraf  Nonium, Model display 
panel Standard, NR 1475.801, Holland) at a low load, 
each training session lasted 30 minutes and ended with 
5-minute recovery and relaxation phase) either walking 
or running, based on heart rate, until the target heart 
rate was reached, according to American College of  
Sport Medicine guidelines25. The program begun with 
10 min of  stretching and was conducted using the max-
imal heart rate index (HRmax) estimated by 220-age. 
First 2 weeks = 60–70% of  HRmax, 3rd to 12th weeks 
= 70–80% of  HRmax. Each session was continued for 
30 minutes; 3 sessions / week for 3 months26.  
All subjects of  group (A) were instructed to take an in-
dividual balanced energy-restricted dietary program to 
obtain weight loss .The mean daily caloric intake was 
about1200 kcal/day, based on a macronutrient content 
<30% fat and 15% protein as recommended by the 
World Health Organization27. At the initial interview 
with a dietitian, obese subjects was given verbal and 
written instructions on how to keep diet records, with 
food weighed and measured. Dietary intake was mon-
itored by the same dietitian. The subjects maintained a 
detailed record of  food intake, and received weekly nu-
tritional counseling. Obese subjects were instructed to 
substitute low-fat alternatives for typical high-fat foods, 
to increase the consumption of  vegetables and fresh 
fruits, and to substitute complex carbohydrates, such as 
whole-grain bread and cereals. Dietetic help was giv-
en every 2 weeks by the dietitian when anthropometric 
measurements were performed; in addition, each sub-
ject was seen by a physician monthly to perform a clin-
ical evaluation, standard electrocardiogram, and meas-
urement of  blood pressure and heart rate26,28. 
504               505African Health Sciences Vol 15 Issue 2, June 2015African Health Sciences Vol 15 Issue 2, June 2015
2. Patients in Group (B) received no training or diet 
regimen for three months.
Statistical analysis
The mean values of  BMI, Leptin, TC, HDL-c, LDL-c, 
TG, RSES, BDI and POMS obtained before and af-
ter three months in both groups were compared using 
paired "t" test. Independent "t" test was used for the 
comparison between the two groups (P<0.05).
   
Results
The two groups were considered homogeneous regard-
ing the baseline characteristics (Table 1). 
 
                                           Table (1): Demonstrates the baseline characteristics of all participants. 
 
Parameters                           
Mean + SD 
p value Group A (N = 50) 
 
Group B (N = 50) 
 
Age (years) 36.35 ± 5.11 37.16 ± 4.32 P > 0.05 
Waist circumference (cm) 107.54 ± 8.38 106.18 ± 7.13 P > 0.05 
Hip circumference (cm) 113.17 ± 7.82 112.95 ± 8.11 P > 0.05 
Waist to hip ratio 0.91 ± 0.14 0.89 ± 0.13 P > 0.05 
Body weight (kg) 94.26 ± 8.27 92.97 ± 7.82 P > 0.05 
Systolic blood pressure 
(mm Hg) 142.16 ± 10.54 140.34 ± 11.12 
P > 0.05 
Diastolic blood pressure 
(mm Hg) 87.13 ± 8.23 85.15 ± 7.21 
P > 0.05 
Fasting glucose (mg/dl) 128.37 ± 10.18 127.87 ± 9.87 P > 0.05 
HbA1c % 7.93 ± 1.86 7.26 ± 1.55 P > 0.05 
Total cholesterol (mg/dl) 192.30± 12.86 193.54± 11.22 P > 0.05 
HDL-cholesterol (mg/dl) 34.54± 2.71 33.73± 2.95 P > 0.05 
LDL-cholesterol (mg/dl) 132.93± 9.78 133.64± 9.03 P > 0.05 
Triglyceride (mg/dl) 154.15± 10.21 155.18± 9.82 P > 0.05 
      BMI = Body Mass Index; HbA1c = Hemoglobin A1C; HDL= High Density Lipoprotein; LDL= Low  
       Density Lipoprotein 
There was a significant decrease in body mass index 
(BMI), leptin, total cholesterol (TC), low density lipo-
protein cholesterol (LDL-c), triglycerides(TG), home-
ostasis model assessmentinsulin resistance- index (HO-
MA-IR) , Beck depression inventory (BDI )  & profile 
of  mood states(POMS) and  increase in high density 
lipoprotein cholesterol (HDL-c) & Rosenberg self-es-
teem scale (RSES) of  group (A) after treatments (Table 
2), but the changes of  group (B) were not significant 
(Table 3). 
Table (2): Mean value and significance of BMI, Leptin, TC, HDL-c, LDL-c, TG, HOMA-
IR, RSES, BDI and POMS of group (A) before and after treatment. 
 
 Mean +SD T-value P-value 
Before After 
BMI (Kg/m2) 32.86± 5.29 30.13± 4.32 5.26 P <0.05 
Leptin (Ng/ml) 39.72± 5.75 36.21± 5.195 6.31 P <0.05 
TC (mg/dl) 192.30± 12.86 176.54± 11.66 9.75 P <0.05 
HDL-c  (mg/dl) 34.54± 2.71 36.35± 2.48 6.24 P <0.05 
LDL-c  (mg/dl) 132.93± 9.78 120.27± 8.94 7.22 P <0.05 
TG (mg/dl) 154.15± 10.21 129.61± 9.83 8.35 P <0.05 
HOMA-IR 7.21 ± 2.13 5.65 ± 1.94 4.31 P <0.05 
Self-esteem (RSES) 21.12 ± 3.45 26.73 ± 3.22 5.61 P <0.05 
Depression (BDI) 7.98 ± 2.05 5.21 ± 1.97 3.32 P <0.05 
Total mood disturbance 
(POMS) 23.95 ± 4.42 19.61 ± 4.13 5.11 P <0.05 
BMI = Body Mass index; TC = Total cholesterol; HDL-c = High-density lipoprotein cholesterol; LDL-
c= Low-density lipoprotein cholesterol; TG = Triglyceride;     HOMA-IR = Homeostasis Model 
Assessment-Insulin Resistance Index; RSES = Rosenberg Self-Esteem Scale; BDI = Beck Depression 
Inventory; POMS = Profile of Mood States. 
 
 
Table (3): Mean value and significance of BMI, Leptin, TC, HDL-c, LDL-c, TG, 
HOMA-IR, RSES, BDI and POMS of group (B) before and after treatment. 




BMI (Kg/m2) 33.15± 4.87 33.45± 4.16 0.82 P > 0.05 
Leptin (Ng/ml) 38.64± 5.16 38.91± 4.37 0.98 P > 0.05 
TC (mg/dl) 193.54± 11.22 195.12± 10.25 1.25 P > 0.05 
HDL-c  (mg/dl) 33.73± 2.95 32.81± 2.74 0.89 P > 0.05 
LDL-c  (mg/dl) 133.64± 9.03 133.88± 8.72 0.95 P > 0.05 
TG (mg/dl) 155.18± 9.82 156.11± 9.23 1.12 P > 0.05 
HOMA-IR 7.53 ± 2.32 7.81 ± 2.15 0.81 P > 0.05 
Self-esteem (RSES) 20.54 ± 3.72 19.82 ± 3.43 0.93 P > 0.05 
Depression (BDI) 8.15 ± 2.14 8.41 ± 2.11 0.62 P > 0.05 
Total mood disturbance 
(POMS) 24.04± 4.31 24.22± 4.16 0.86 P > 0.05 
BMI = Body Mass index; TC = Total cholesterol; HDL-c = High-density lipoprotein cholesterol; 
LDL-c= Low-density lipoprotein cholesterol; TG = Triglyceride;     HOMA-IR = Homeostasis Model 
Assessment-Insulin Resistance Index; RSES = Rosenberg Self-Esteem Scale; BDI = Beck Depression 
Inventory; POMS = Profile of Mood States. 
Moreover, there were significant differences between 
mean levels of  the investigated parameters of  group 
(B) and group (A) at the end of  the study (Table 4). 
(P<.05).
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Discussion
The psychological effects of  dieting and weight loss 
have been a matter of  controversy in the field of  obesi-
ty management. Several early studies (before the 1970s) 
described negative emotional consequences to dieting 
29, whereas later studies found an improvement or no 
changes in the symptoms of  depression , self-esteem , 
mood and anxiety in patients that are obese treated by 
behavior modification combined with moderate calo-
rie restriction30-33.These conflicting results constitute an 
incentive to conduct our study to the impact of  weight 
loss as a result of  aerobic exercise training and dietary 
measures on psychological wellbeing and biochemical 
modulation in obese type 2 diabetes patients.
The findings of  this study showed that weight loss be-
cause of  aerobic exercise training and dietary measures 
by obese type 2 diabetic patients led to decreased BMI, 
Leptin, TC, LDL-c, TG& HOMA-IR and increased 
HDL-c. Accumulating evidence confirms these find-
ings indicates that lifestyle changes such as weight loss 
and regular physical activity are recognized as effective 
non-pharmacological interventions with beneficial ef-
fects and biochemical modulation in obese type 2 dia-
betes patients34-36.
Table (4): Mean value and significance of BMI, Leptin, TC, HDL-c, LDL-c, TG, HOMA-
IR, RSES, BDI and POMS of group (A) and group (B) after treatment. 
 
 Mean +SD T-value P-value 
Group (A) Group (B) 
BMI (Kg/m2) 30.13± 4.32 33.45± 4.16 4.75 P <0.05 
Leptin (Ng/ml) 36.21± 5.195 38.91± 4.37 5.62 P <0.05 
TC (mg/dl) 176.54± 11.66 195.12± 10.25 8.55 P <0.05 
HDL-c  (mg/dl) 36.35± 2.48 32.81± 2.74 5.42 P <0.05 
LDL-c  (mg/dl) 120.27± 8.94 133.88± 8.72 6.34 P <0.05 
TG (mg/dl) 129.61± 9.83 156.11± 9.23 7.61 P <0.05 
HOMA-IR 5.65 ± 1.94 7.81 ± 2.15 3.45 P <0.05 
Self-esteem (RSES) 26.73 ± 3.22 19.82 ± 3.43 4.21 P <0.05 
Depression (BDI) 5.21 ± 1.97 8.41 ± 2.11 3.12 P <0.05 
Total mood disturbance 
(POMS) 19.61 ± 4.13 24.22± 4.16 4.10 P <0.05 
BMI = Body Mass index; TC = Total cholesterol; HDL-c = High-density lipoprotein cholesterol; LDL-
c= Low-density lipoprotein cholesterol; TG = Triglyceride;     HOMA-IR = Homeostasis Model 
Assessment-Insulin Resistance Index; RSES = Rosenberg Self-Esteem Scale; BDI = Beck Depression 
Inventory; POMS = Profile of Mood States. 
Pi-Sunyer etal. found that an intensive lifestyle inter-
vention for type 2 diabetes patients was associated with 
an average of  8.6% body weight loss compared with 
0.7% in the diabetes support and education (control) 
group after one year ,this was accompanied by an A1C 
reduction from 7.3% to 6.6%, along with improved fit-
ness level, blood pressure and lipid values. The weight 
changes were significantly correlated with changes in 
glycemic control, blood pressure, high-density lipo-
protein cholesterol, and triglycerides; larger weight loss 
resulted in greater improvements in each of  the cardio-
vascular risk factors34. 
Snel et al. included 27 obese type 2 diabetes patients in a 
16-week very low calorie diet and exercise program and 
found that a significant weight loss, glycemic control 
and major improvements in health-related quality of  
life35. Moreover, Jazet etal. applied a study on eighteen 
insulin-treated obese type 2 diabetes patients who were 
followed for 18 months after they followed a 30-day 
very low calorie diet (VLCD, 450 k Cal/day) with the 
cessation of  all glucose-lowering medication. After the 
30-day VLCD, caloric intake was slowly increased and 
glucose-lowering medication was restarted if  necessary. 
On day 0 and 30 of  the VLCD and after 18 months 
follow-up, bodyweight, blood pressure, glycemic con-
trol and lipid levels were measured. The 30-day VLCD 
significantly reduced bodyweight and waist circumfer-
ence and improved dyslipidemia, hypertension and gly-
caemia36. 
This study also showed weight loss because of  aerobic 
exercise training and dietary measures by obese type 2 
diabetes patients led to decreased Beck depression in-
ventory (BDI) & profile of  mood states (POMS) and 
increased Rosenberg self-esteem Scale (RSES). In this 
regard, some studies revealed that the weight loss has a 
strong impact on psychological wellbeing in obese type 
2 diabetes patients37-41.
Grave et al. investigated the effects of  weight loss on 
psychological distress and binge eating in 500 patients 
that are obese of  both sexes remaining in continuous 
treatment at different centers with slightly different 
strategies. At baseline and after 12 months all subjects 
were evaluated by the SymptomCheckList-90 Global 
Severity Index (SCL-GSI) and by the Binge eating scale 
(BES). In both males and females, weight loss was asso-
ciated with improved psychometric testing of  psycho-
logical distress37. However, in a systematic review of  22 
studies of  long-term non-pharmacological weight loss 
interventions in type 2 diabetes through health behav-
ior changes for 1 to 5 years, the pooled weight loss was 
a modest 1.7 kg, or 3.1%34. The compelling evidence on 
modest weight loss in the prevention or delay in type 
2 diabetes raised the tantalizing question of  whether 
long-term lifestyle intervention exert beneficial health 
and cardiovascular outcomes in type 2 diabetes38.  
Imayama et al. Conducted a randomized controlled tri-
al on overweight/obese postmenopausal women ran-
domly for 12 months  and found that a  combined diet 
and exercise intervention resulted in weight loss and 
had positive effects on health-related quality of  life and 
psychological health which included depression, anxie-
ty and social support39. While, Wycherley etal. conduct-
ed in a parallel design, a study on 106 obese men and 
women  with type 2 diabetes who were randomized to a 
prescriptive 16-week caloric restricted diet (6,000–7,000 
kJ/day), with supervised resistance exercise training (n 
= 65) or without supervised resistance exercise training 
(n = 41) (three times per week) and found that  struc-
tured caloric restricted diet with or without resistance 
exercise training improves body weight, glycated hemo-
globin, diabetes-specific emotional distress  and qual-
ity of  life questionnaire in overweight and obese pa-
tients with type 2 diabetes40. Moreover, Faulconbridge 
etal. studied the response of  depression symptoms 
to changes in body weight and stated that intentional 
weight loss is often accompanied by improvements in 
mood of  depressed individuals41.  
   
Our results revealed that BMI and serum leptin were 
significantly decreased upon weight loss among obese 
type 2 diabetes patients. Our findings were consistent 
with Sartorio and colleagues who proved that the circu-
lating levels of  leptin have been shown to decrease in 
response to decreases in energy availability42, also Volek 
and colleagues suggested that significant decreases in 
leptin occur as part of  an 8-week weight loss program43, 
which similarly occurred in the present study.
Leptin is recognized to play an integral role in endocrine 
regulation of  metabolism. The higher serum leptin level 
in obese subjects was clearly evident to be decreased 
during calorie restriction44. Reduction in leptin concen-
trations is not only due to decreased body fat mass but 
potentially through an increase in leptin sensitivity45. 
Moreover, leptin signaling to brain stem hypothalamic 
pathways potentially increases the brain's motor and au-
tonomic responses to satiety signals, leading to smaller 
individual meals; reduce cumulative food intake, and a 
lowers body weight46. The decrease in serum leptin level 
after weight reduction was correlated with reduction in 
BMI47. Weight loss and decrease in BMI in obese diabe-
tes patients was due to enhanced fat oxidation48. 
Finally, the results of  the present study regarding HO-
MA-IR showed that weight loss resulted in decrease in 
HOMA-IR, this result confirmed by  Younger and col-
leagues reported that increased physical activity leads 
to improvement in insulin resistance and increase in 
muscle oxidative capacity which are likely contribute 
to the beneficial effects of  exercise training on insu-
lin action49. Also, Kriska and colleagues confirmed that 
physical activity in obese non-insulin dependent diabe-
tes mellitus decreased blood glucose level through im-
proving insulin sensitivity and decreasing deposition of  
total fat and intra-abdominal fat. Also, physical activity 
is negatively associated with insulin concentration as a 
defense mechanism50. However, Roland and colleagues 
stated that exercise training improves insulin sensitivity 
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and glycemic control, increases muscle mass, strength 
and endurance51. Also, Sato and colleagues and Short et 
al. found that physical exercise promotes utilization and 
lowering of  blood glucose. This improvement in insulin 
action was attributed to the increase in insulin sensitive 
glucose transporter on the plasma membrane and oxi-
dative enzymes in skeletal muscle52,53. While, Albu and 
colleagues mentioned that lifestyle modifications with 
diet and exercise are essential part of  the management 
of  the diabetes obese patient as weight loss leads to im-
provement in the glucose tolerance, insulin sensitivity, 
reductions in lipid levels54. Weight reduction program 
consisted of  diet restriction and exercise which was 
conducted on thirty-five obese NIDDM patients for 
twelve weeks (diet restriction and exercise) induced sig-
nificant reductions in body weight, serum leptin levels, 
improvements in lipoprotein profile, insulin sensitivity 
and glucose control55.  Energy restriction resulting in 
even modest weight loss suppresses endogenous cho-
lesterol synthesis which leads to a decline in circulating 
lipid concentrations and as a result increased insulin 
sensitivity56,57. Through decreasing deposition of  total 
fat and intra-abdominal fat58.
Conclusion
Weight loss because of  aerobic exercise training and di-
etary measures can be considered as methods of  choice 
for psychological wellbeing and biochemical modula-
tion in obese type 2 diabetes patients. 
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